Gross Profit: Revenues from operations less the associated costs.
Aurinia Pharmaceuticals Inc (AUPH) had Gross Profit of $71.20M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$77.70M |
|
$34.35M |
|
$6.50M |
|
|
Gross Profit |
$71.20M |
$36.00M |
|
$41.70M |
|
$2.22M |
|
$43.92M |
|
$43.92M |
|
$34.35M |
|
$34.35M |
|
$34.35M |
|
$34.35M |
|
$41.70M |
|
$46.52M |
|
132.38M |
|
137.64M |
|
$0.26 |
|
$0.25 |
|
| Balance Sheet Financials | |
$480.24M |
|
$1.99M |
|
$243.75M |
|
$724.00M |
|
$86.56M |
|
$48.18M |
|
$69.81M |
|
$156.37M |
|
$567.63M |
|
$564.04M |
|
$567.63M |
|
130.77M |
|
| Cash Flow Statement Financials | |
$32.56M |
|
$-18.08M |
|
$-53.69M |
|
$80.21M |
|
$41.01M |
|
$-39.20M |
|
$-0.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.55 |
|
-- |
|
-- |
|
0.08 |
|
0.11 |
|
91.63% |
|
53.67% |
|
53.67% |
|
-- |
|
56.53% |
|
44.21% |
|
$32.52M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.14 |
|
1.58 |
|
56.96 |
|
6.05% |
|
6.09% |
|
4.75% |
|
5.58% |
|
$4.34 |
|
$0.24 |
|
$0.24 |
|